Suzie Marshall
Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs
Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies (CVT) to develop no...
CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected
In a new statement published on 2 April 2020, all 45 societies represented by the US Council of Medi...
Biotronik appoint company’s first chief medical officer
David Hayes, former physician administrator at Mayo Clinic, Rochester, USA, has been appointed c...
Enrolment completed for MASTER DAPT trial
A significant milestone has been reached for a landmark study into the use of short du...
ADAPT tissue is “going to be a game-changer” regarding durability in aortic valves
Michael Reardon (Houston, USA) talks to BLearning Cardio about the ADAPT tissue technology (Admedus)...
Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients
The National Institute for Health and Care Excellence (NICE) has published the final appraisal deter...
Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and comme...
Scott Gottlieb resigns as head of US FDA
The commissioner of the US Food and Drug Administration (FDA), Scott Gottlieb, has unexpectedly ...
CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial
The Peregrine system infusion catheter (Ablative Solutions) has demonstrated 100% procedural suc...
US government shutdown disrupting FDA work
The US government shutdown means the country’s Food and Drug Administration (FDA) cannot accept ...
Unique therapeutic approach to treating uncontrolled hypertension receives US$77 million financing
Ablative Solutions has announced the first close of its US$77 million Series D funding round. The ro...
FDA releases final rule on acceptance of data from clinical investigations for medical devices
The Food and Drug Administration (FDA) has today issued the final rule on “human subject protect...
